Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Benzimidazoles Stories

2012-06-01 06:23:24

FORT WORTH, Texas, June 1, 2012 /PRNewswire/ -- A motion was filed on May 30, 2012 with the United States Judicial Panel on Multidistrict Litigation (JPML) petitioning for the creation of a coordinated federal MDL for all cases concerning the anticoagulant drug Pradaxa (dabigatran etexilate mesylate). The motion seeks to transfer pending cases and future claims relating to Pradaxa to the United States District Court for the Southern District of Illinois for consolidation. The United States...

2012-05-21 23:00:54

In April 2012, MHRA published an article revealing that there is recent epidemiological evidence of an increased risk of fracture with long-term use of PPIs (Proton Pump Inhibitors), including Nexium. Nexium, manufactured by AstraZeneca, is a medication that people take to prevent on-going heartburn. According to court documents, on April 19th, 2011, an Ohio woman, Ginny Begin, filed a lawsuit Texas Southern District Court (case no. 4:2011cv01489) against AstraZeneca, alleging that she...

2012-05-15 02:29:41

THE WOODLANDS, Texas, May 15, 2012 /PRNewswire/ -- Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients....

2012-05-03 02:32:08

RIDGEFIELD, Conn., May 3, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the GLORIA(TM)-AF Registry Program, the largest prospective observational study in non-valvular atrial fibrillation (NVAF) planned at this time. With a goal of enrolling 56,000 patients, the registry aims to understand the long-term use of antithrombotic treatments to reduce the risk of stroke in patients with NVAF. GLORIA-AF will follow newly-diagnosed...

2012-04-18 02:28:32

RIDGEFIELD, Conn., April 18, 2012 /PRNewswire/ -- A new retrospective sub-analysis of the 18,113 patient RE-LY® trial showed lower rates of intracranial hemorrhage (ICH), including both fatal and traumatic ICH, for Pradaxa® (dabigatran etexilate mesylate) capsules 150mg taken twice daily compared with warfarin. Results of the sub-analysis recently were published online in Stroke: The Journal of the American Heart Association. Intracranial hemorrhage can be a devastating complication...

2012-03-05 08:00:00

On February 8th, 2012 the U.S. FDA issued a warning on drugs called proton pump inhibitors (PPIs) — including Prilosec - that might increase the risk of a type of chronic diarrhea and lead to severe intestinal problems and, in rare cases, death. Prilosec is a proton pump inhibitor (PPI) prescribed to treat acid reflux, stomach ulcers and other conditions. Moreover, in May 2010, the FDA announced that the safety labeling for proton pump inhibitors would be updated to include information...

Brazil Denied Request To Extend Regulation Of Fungicide In Orange Juice
2012-02-17 13:22:47

Brazilian orange juice producers were denied a request on Thursday by the U.S. Food and Drug Administration (FDA) to allow a higher tolerance of fungicide in juice imports. The decision will see that Brazil, the world's top orange juice producer, stops exporting orange juice that is made from concentrate to the U.S. A variety of orange juice made from concentrate contains much smaller levels of carbendazim, a chemical used to help fight mold on orange trees. Carbendazim is permitted...

2012-01-30 05:00:00

LONDON, Jan. 30 2012 /PRNewswire/ -- Today Johnson & Johnson joined the World Health Organization (WHO), 12 other pharmaceutical companies, the Bill & Melinda Gates Foundation, the U.S. and U.K. governments, the World Bank, and officials from endemic countries in a new, coordinated action to eliminate or control by the end of the decade 10 neglected tropical diseases (NTDs) that affect more than a billion people in the world. To view the multimedia assets associated with...

2012-01-25 04:44:15

Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton pump inhibitor lansoprazole, compared to patients who received placebo, according to a study in the January 25 issue of JAMA. Use of lansoprazole was associated with increased adverse events. "Asthma and gastroesophageal reflux (GER) disease are both common disorders in...

2012-01-19 06:00:00

WOBURN, Mass., Jan. 19, 2012 /PRNewswire/ -- CutisPharma, Inc. announced the introduction of FIRST® - Omeprazole and FIRST® - Lansoprazole Unit-of-Use oral suspension compounding kits. These new kits will help pharmacists dispense these compounded prescriptions containing widely used proton pump inhibitors (PPIs). Traditionally, compounded omeprazole and lansoprazole oral suspensions can take up to several hours to prepare and are quite unpleasant to the taste. With...